Recording intelligenceAI-generated brief · check the source for context

Medications Reshape Gut Microbiome

53:55 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Michael Schmidt walks through an open-access Cell paper published November 26, 2025 by a team of 11 from Stanford University, the Chan Zuckerberg Biohub, West Link University in Hangzhou and Tsinghua University in Beijing, titled "Nutrient Competition Predicts Gut Microbiome Restructuring under drug perturbations".3:23
  • Screening over 700 clinically relevant drugs, the authors found 141 common medications significantly alter the microbiome, including the blood pressure drug Losartan that Schmidt himself takes.6:22
  • The driver is not toxicity but fitness: a tug of war in which the bacteria best at grabbing the remaining nutrients win the day, some species go extinct and never come back, and 51 of the 69 antibacterial drugs inhibited growth while anti-neoplastic agents actually enriched growth.7:46
  • Mark O. Martin then presents a Nature Microbiology paper from Cambridge, the United Arab Emirates University and Royal Papworth Hospital, by Santiago Caño Muñez, Floto and many co-authors, combining microbial genetics, single-cell imaging, labelled substrates and optogenetics.29:37
  • They show porin permeability is regulated by periplasmic hydrogen and potassium ions: a light-activated proton pump switched on with green light at 541 nanometers acidifies the periplasm and the porins close in real time, so the metabolic state of the bacterium decides how much hydrophilic antibiotic gets in.33:48

Brief overview

Two papers show drugs reshape gut microbes through nutrient competition, and bacterial metabolism gates antibiotic entry.

  1. Medications reshape the gut by changing the menuThe drug shifts which nutrients are available, and the microbes best at grabbing them take over the ecosystem.
  2. Extinction in the gut can be permanentEven short-term treatments created enduring changes, sometimes wiping out a species entirely unless it is reintroduced.
  3. Metabolic state gates antibiotic entryPeriplasmic protons and potassium set the porin opening, and hydrophilic antibiotics hitchhike in through those porins.

Questions this recording answers

10 questions, each answered where it is said
How many common medications actually change the gut microbiome?

Over 700 clinically relevant drugs were screened, and 141 of them significantly altered the microbiome, including familiar medications such as Losartan, a common blood pressure medicine. The collection covered 116 drugs targeting bacteria, fungi, protozoans and viruses, plus 511 aimed at human physiology.

Answered around 6:14
If not toxicity, what drives the microbiome changes drugs cause?

Not toxicity, as when an antibiotic sets the microbial forest on fire, but fitness: competition for nutrients in a community whose equilibrium the medication disrupted. A tug of war, where the drug changes the food landscape and the bacteria best at grabbing remaining nutrients win, following predictable ecological rules.

Answered around 7:37
Which paper is this, and where was it published?

Nutrient Competition Predicts Gut Microbiome Restructuring under drug perturbations, open access in Cell on November 26, 2025, from a team of 11: Shi, Newton, Nguyen, Estrella, Sanchez, Tu, Ho, Zhang, DeFelice, Sonnenberg and Wang, spanning Stanford, the Chan Zuckerberg Biohub, Westlake University in Hangzhou and Tsinghua University.

Answered around 3:38
What regulates how open a bacterial porin is?

Porin permeability is regulated by the periplasmic concentrations of hydrogen ions and potassium ions. They showed it with a fluorescent glucose analog and single-cell fluorescence microscopy, plus an E. coli knockout library, the CAO collection of about 4,000 strains, implicating OMPF, OMPC and OMPG mutants and the potassium voltage-gated channel.

Answered around 33:48
How do you acidify a bacterium's periplasm on demand?

Optogenetics: they put a light-activated proton pump into the bacterium, ARCH-T, a rhodopsin that archaea use, adding a peptide signal so it inserted into the inner membrane properly. Shining green light at 541 nanometers pumps protons outward, acidifying the periplasm, and the porins are watched closing in real time.

Answered around 35:18
What was in the collection of 707 drugs they screened?

A clinical collection of 707 small molecules: 511 targeted human-specific processes such as hypertension, 69 targeted bacteria, 13 targeted fungi, and 75 were not drugs at all, with disinfectants thrown into the mix. Of the 69 antibacterials, 51 inhibited growth, five targeted Mycobacterium tuberculosis and six were beta-lactams.

Answered around 13:19
How did they grow and measure these gut communities?

Stool-derived in vitro communities from nine separate donors, passed through a gnotobiotic animal, then grown anaerobically in microtiter plates on brain heart infusion agar. Growth dynamics were monitored by optical density and area under the curve, with 16S ribosomal RNA sequencing and untargeted metabolomics reading out who was there.

Answered around 12:28
Why can't you just swallow butyrate to feed good gut bacteria?

Because the other microbes behave like porch pirates, snatching that Amazon package of butyrate off the collective porch before the microbe you meant to feed can use it for good. Every pharmaceutical and supplement is a disruptor of a delicate equilibrium, shifting who gets the limited metabolites and small molecules.

Answered around 9:20
What are the limits of studying the microbiome in a dish?

The communities came from fecal samples, and bacteria in poop are only a reasonable representation of the digestive system; the action happens upstream in the small intestine, which the authors are now trying to sample with ingestible technology. Culturing also removes the host immune system, peristalsis, dilution, flow and the liver.

Answered around 19:15
Why does porin regulation matter for antibiotic treatment?

There is longstanding controversy about antibiotic susceptibility changing with growth medium or culture conditions, which can matter clinically, and porin state appears to explain that apparent innate resistance, since hydrophilic antibiotics hitchhike in through porins. Therapeutically activating the potassium channel might make cells more sensitive to antibiotics.

Answered around 43:57
Key Quote

“Simply, it's a tug of war.”

— Michael Schmidt, Medications Reshape Gut Microbiome, at 6:59▶ listen at 6:59
Key Quote

“So Michael, what did they do?”

— Vincent Racaniello, Medications Reshape Gut Microbiome, at 11:33▶ listen at 11:33
Key Quote

“So I think the way to look at this paper is not what it tells us, but how it's analyzing the problem.”

— Petra Levin, Medications Reshape Gut Microbiome, at 21:55▶ listen at 21:55
Key Quote

“I think the term is quantitative microbiology, not data science, because they did the experiment.”

— Vincent Racaniello, Medications Reshape Gut Microbiome, at 25:00▶ listen at 25:00
Key Quote

“I loved this paper.”

— Mark O. Martin, Medications Reshape Gut Microbiome, at 31:41▶ listen at 31:41
Key Quote

“Guess what? It's not. Bacteria are never leaky.”

— Mark O. Martin, Medications Reshape Gut Microbiome, at 49:11▶ listen at 49:11

Cite this

“Medications Reshape Gut Microbiome.” https://traffic.libsyn.com/secure/twimshow/TWiM346.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/medications-reshape-gut-microbiome.html.

Report this page
What is wrong with this page?